1. Home
  2. ANVS vs SQNS Comparison

ANVS vs SQNS Comparison

Compare ANVS & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • SQNS
  • Stock Information
  • Founded
  • ANVS 2008
  • SQNS 2003
  • Country
  • ANVS United States
  • SQNS France
  • Employees
  • ANVS N/A
  • SQNS N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • SQNS Semiconductors
  • Sector
  • ANVS Health Care
  • SQNS Technology
  • Exchange
  • ANVS Nasdaq
  • SQNS Nasdaq
  • Market Cap
  • ANVS 44.6M
  • SQNS 46.5M
  • IPO Year
  • ANVS 2020
  • SQNS 2011
  • Fundamental
  • Price
  • ANVS $2.75
  • SQNS $4.52
  • Analyst Decision
  • ANVS Strong Buy
  • SQNS Strong Buy
  • Analyst Count
  • ANVS 4
  • SQNS 1
  • Target Price
  • ANVS $18.00
  • SQNS $7.50
  • AVG Volume (30 Days)
  • ANVS 437.3K
  • SQNS 9.6M
  • Earning Date
  • ANVS 08-14-2025
  • SQNS 08-22-2025
  • Dividend Yield
  • ANVS N/A
  • SQNS N/A
  • EPS Growth
  • ANVS N/A
  • SQNS N/A
  • EPS
  • ANVS N/A
  • SQNS 2.16
  • Revenue
  • ANVS N/A
  • SQNS $38,858,000.00
  • Revenue This Year
  • ANVS N/A
  • SQNS N/A
  • Revenue Next Year
  • ANVS N/A
  • SQNS $93.87
  • P/E Ratio
  • ANVS N/A
  • SQNS $1.81
  • Revenue Growth
  • ANVS N/A
  • SQNS 40.06
  • 52 Week Low
  • ANVS $1.11
  • SQNS $0.95
  • 52 Week High
  • ANVS $14.80
  • SQNS $5.50
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 57.81
  • SQNS 87.95
  • Support Level
  • ANVS $2.24
  • SQNS $1.34
  • Resistance Level
  • ANVS $2.97
  • SQNS $2.68
  • Average True Range (ATR)
  • ANVS 0.26
  • SQNS 0.52
  • MACD
  • ANVS 0.02
  • SQNS 0.29
  • Stochastic Oscillator
  • ANVS 65.58
  • SQNS 76.77

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

Share on Social Networks: